XML 65 R47.htm IDEA: XBRL DOCUMENT
v3.25.1

Share Based Awards (Tables) | 8 Months Ended
--- | ---
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract] |
Schedule of Assumptions Used to Calculate the Fair Value of Options Granted | The range of assumptions used to calculate the fair value of options granted during the eight months ended December 31, 2024 was: Schedule of Assumptions Used to Calculate the Fair Value of Options Granted
Exercise Price |  |  | $ 1.15 – 4.02 |
Stock price on date of grant |  |  | 1.20 – 4.02 |
Risk-free interest rate |  |  | 3.54 – 4.44 | %
Dividend yield |  |  | — |
Expected term (years) |  |  | 5.17 – 5.78 |
Volatility |  |  | 190.46 – 199.03 | %
The range of assumptions used to calculate the fair value of options granted during the year ended April 30 was:
|  | 2024 |  |  | 2023 |
Exercise Price |  | $ | 0.72 – 1.12 |  |  | $ | 0.89 – 2.38 |
Stock price on date of grant |  |  | 0.70 – 1.12 |  |  |  | 0.89 – 2.38 |
Risk-free interest rate |  |  | 3.46 – 4.41 | % |  |  | 3.34 – 4.18 | %
Dividend yield |  |  | — |  |  |  | — |
Expected term (years) |  |  | 5.28 – 8.25 |  |  |  | 6.25 – 8.25 |
Volatility |  |  | 206.99 – 262.07 | % |  |  | 245.57 – 260.06 | %
Schedule of Options Activity | A summary of options activity under the Plan since April 30, 2022 was: Schedule of Options Activity
|  | Shares |  |  | Weighted- Average Exercise Price |  |  | Weighted- Average Remaining Contractual Term |  |  | Aggregate Intrinsic Value |
Outstanding as of April 30, 2022 |  |  | 3,694,142 |  |  | $ | 2.17 |  |  |  | 8.56 |  |  |  | 1,407,545 |
Granted |  |  | 1,503,500 |  |  |  | 1.40 |  |  |  |  |  |  |  |  |
Exercised |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |
Forfeited or expired |  |  | (412,833 | ) |  |  | 2.67 |  |  |  |  |  |  |  |  |
Outstanding as of April 30, 2023 |  |  | 4,784,809 |  |  |  | 1.88 |  |  |  | 8.72 |  |  |  | 74,586 |
Granted |  |  | 2,903,542 |  |  |  | 1.02 |  |  |  |  |  |  |  |  |
Exercised |  |  | (3,000 | ) |  |  | 0.89 |  |  |  |  |  |  |  |  |
Forfeited or expired |  |  | (905,417 | ) |  |  | 2.27 |  |  |  |  |  |  |  |  |
Outstanding as of April 30, 2024 |  |  | 6,779,934 |  |  |  | 1.46 |  |  |  | 8.02 |  |  |  | 2,762,242 |
Granted |  |  | 1,463,500 |  |  |  | 2.14 |  |  |  |  |  |  |  |  |
Exercised |  |  | (2,475,242 | ) |  |  | 1.69 |  |  |  |  |  |  |  |  |
Forfeited or expired |  |  | (122,867 | ) |  |  | 1.45 |  |  |  |  |  |  |  |  |
Outstanding as of December 31, 2024 |  |  | 5,645,325 |  |  |  | 1.54 |  |  |  | 7.90 |  |  |  | 59,779,836 |
Exercisable as of December 31, 2024 |  |  | 1,924,275 |  |  | $ | 1.31 |  |  |  | 6.13 |  |  | $ | 22,212,003 |
Schedule of Restricted Stock Activity | A summary of restricted stock activity under the Plan since April 30, 2022 was: Schedule of Restricted Stock Activity
|  | Shares |  |  | Weighted Average Grant-Date Fair Value Per Share |
Unvested and outstanding as of April 30, 2022 |  |  | 1,083,675 |  |  | $ | 2.59 |
Granted |  |  | 780,884 |  |  |  | 2.14 |
Vested |  |  | (1,062,372 | ) |  |  | 2.42 |
Forfeited |  |  | (21,127 | ) |  |  | 2.13 |
Unvested and outstanding as of April 30, 2023 |  |  | 781,060 |  |  |  | 2.44 |
Granted |  |  | 298,643 |  |  |  | 1.06 |
Vested |  |  | (485,024 | ) |  |  | 1.92 |
Forfeited |  |  | (419,549 | ) |  |  | 2.09 |
Unvested and outstanding as of April 30, 2024 |  |  | 175,130 |  |  | $ | 2.09 |
Granted |  |  | 3,072,599 |  |  |  | 2.58 |
Vested |  |  | (1,403,702 | ) |  |  | 1.43 |
Forfeited |  |  | (300,000 | ) |  |  | 1.14 |
Unvested and outstanding as of December 31, 2024 |  |  | 1,544,027 |  |  | $ | 3.84 |
Schedule of Stock Compensation Expense by Functional Operating Expense | Stock compensation expense by functional operating expense was: Schedule of Stock Compensation Expense by Functional Operating Expense
|  | December 31, 2024 |  |  | April 30, 2024 |  |  | April 30, 2023 |
Research and development |  | $ | 239,664 |  |  | $ | 395,105 |  |  | $ | 692,947 |
Sales and marketing |  |  | 1,040,260 |  |  |  | 562,110 |  |  |  | 566,153 |
General and administrative |  |  | 2,823,110 |  |  |  | 2,652,052 |  |  |  | 2,397,624 |
Total |  | $ | 4,103,034 |  |  | $ | 3,609,267 |  |  | $ | 3,656,724 |

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the changes in outstanding nonvested restricted stock shares. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Subparagraph (c) -Paragraph 2 -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration